ResearcherNanjing General Hospital of Nanjing Military CommandNo recent work listed

Xiaoyuan Chu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7917-7874; OpenAlex author ID A5100636550. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2021: 1 paper

Papers 1

Clinical Effects of Stereotactic Body Radiation Therapy Targeting the Primary Tumor of Liver-Only Oligometastatic Pancreatic Cancer. Last author DOI 10.3389/fonc.2021.659987 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xiaoqin Ji · 1 shared paper, 2021 · strength 0.14
- Paper Clinical Effects of Stereotactic Body Radiation Therapy Targeting the Primary Tumor of Liver-Only Oligometastatic Pancr… DOI 10.3389/fonc.2021.659987 ↗
Zetian Shen · 1 shared paper, 2021 · strength 0.14
- Paper Clinical Effects of Stereotactic Body Radiation Therapy Targeting the Primary Tumor of Liver-Only Oligometastatic Pancr… DOI 10.3389/fonc.2021.659987 ↗
Cheng Yeh Chen · 1 shared paper, 2021 · strength 0.14
- Paper Clinical Effects of Stereotactic Body Radiation Therapy Targeting the Primary Tumor of Liver-Only Oligometastatic Pancr… DOI 10.3389/fonc.2021.659987 ↗
Xixu Zhu · 1 shared paper, 2021 · strength 0.14
- Paper Clinical Effects of Stereotactic Body Radiation Therapy Targeting the Primary Tumor of Liver-Only Oligometastatic Pancr… DOI 10.3389/fonc.2021.659987 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.